评估贝克西沙林用于治疗发育性性脑病变
Giovanni Battista Dell'isola1, Alberto Verrotti1, Miriam Sciaccaluga2,3
1Department of Pediatrics, University of Perugia, Perugia, Italy.
Expert opinion on pharmacotherapy
|June 25, 2024
概括
贝克西卡塞林是一种5-HT2C受体激动剂,显示出作为发育性脑病变 (DEE) 的辅助疗法的前景. 临床试验表明,它可以减少运动发作,为耐药性治疗提供了新的希望.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 发育性脑病变 (DEE) 由于其对传统治疗的耐药性,因此存在重大治疗挑战.
- 对DEE的遗传进步尚未转化为针对核心病理生理学的广泛有效疗法.
- 血清激素系统功能障碍越来越多地与有关,将血清激素定位为潜在的治疗标.
研究的目的:
- 探索选择性5-HT2C受体激动剂贝克西沙林 (bexicaserin) 作为DEE辅助抗发作药物的潜力.
- 审查临床前和临床证据,支持贝克西沙林在控制发作的有效性.
主要方法:
- 在各种模型中评估贝克西沙林抗发作作用的临床前研究的综述.
- 对包括太平洋研究在内的临床试验数据的分析,评估贝克西沙林对DEE运动的影响.
- 检查贝克西沙林的拟议作用机制,涉及GABAergic神经传递调节.
主要成果:
- 临床前研究表明,贝克西沙林在各种发作模型中的有效性.
- 临床试验,如太平洋研究,报告了有希望的减少运动发作.
- 观察到的挑战包括不良影响和停止治疗,需要进一步调查.
结论:
- 像贝克西沙林这样的5-HT2C激动剂的疗效支持了血清素在DEE中的作用.
- 贝克西卡塞林呈现了一种新的治疗途径,可能与现有的抗发作药物产生协同作用.
- 进一步的研究是必不可少的,以充分了解贝克西沙林的机制和抗性潜力.
关键词:
5-HT2C的使用方法贝克西卡塞林 (LP352) 是一种抗发作药物 (ASM) 的使用.发育性和性脑病变 (DEE)药物耐药性 (DRE) 是一种血清胺 (serotonin) 是一种神经元.更多相关视频
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.6K
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
20.3K
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
169
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
169
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
01:14Antiepileptic Drugs: Glutamate Antagonists
319
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
319
01:17Antiepileptic Drugs: Calcium Channel Blockers
369
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
369
01:08Antiepileptic Drugs: Sodium Channel Blockers
508
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
508